(Q50783861)

19 March 2018

title

Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial. (English)

1 reference

19 March 2018

2

Ljungman P

1 reference

19 March 2018

Schmitz N

1

1 reference

19 March 2018

Cordonnier C

3

1 reference

19 March 2018

Kempf C

4

1 reference

19 March 2018

Linkesch W

5

1 reference

19 March 2018

Alegre A

6

1 reference

19 March 2018

Solano C

7

1 reference

19 March 2018

Simonsson B

8

1 reference

19 March 2018

Sonnen R

9

1 reference

19 March 2018

Diehl V

10

1 reference

19 March 2018

Fischer T

11

1 reference

19 March 2018

Caballero D

12

1 reference

19 March 2018

Littlewood T

13

1 reference

19 March 2018

Noppeney R

14

1 reference

19 March 2018

Schafhausen P

15

1 reference

19 March 2018

Jost L

16

1 reference

19 March 2018

Delabarre F

17

1 reference

19 March 2018

Marcus R

18

1 reference

19 March 2018

language of work or name

English

0 references

publication date

1 December 2004

1 reference

19 March 2018

Bone Marrow Transplantation

published in

1 reference

19 March 2018

volume

34

1 reference

19 March 2018

issue

11

1 reference

19 March 2018

page(s)

955-962

1 reference

19 March 2018

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704724

exact match

0 references

cites work

Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

Infections during mobilizing chemotherapy and following autologous stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

7 January 2021

G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

7 January 2021

The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant period

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

7 January 2021

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

7 January 2021

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

7 January 2021

Guidelines on the use of colony-stimulating factors in haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

7 January 2021

Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

7 January 2021

Current trends in hematopoietic stem cell transplantation in Europe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704724

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704724

1 reference

19 March 2018

1 reference

19 March 2018